Jefferies Downgrades Atara Biotherapeutics (ATRA) to Hold
Tweet
Share
E-mailGet Alerts ATRA Hot Sheet
Price: $8.28 +2.35%
Rating Summary:
5 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 20
Rating Summary:
5 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 20
Join SI Premium – FREE
Jefferies analyst Maury Raycroft downgraded Atara Biotherapeutics (NASDAQ: ATRA) from Buy to Hold with a price target of $15.00 (from $32.00).
For an analyst ratings summary and ratings history on Atara Biotherapeutics click here. For more ratings news on Atara Biotherapeutics click here.
Shares of Atara Biotherapeutics closed at $15.16 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Canaccord Downgrades York Space Systems (YSS) to Hold, 'Supply chain and contract timing uncertainty'
- EyePoint Inc. (EYPT) PT Lowered to $8 at Jefferies
- Enovix Corporation (ENVX) PT Lowered to $5 at BofA Securities
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
